Does pregabalin (lyrica) cause less dizziness than gabapentin (neurontin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pregabalin vs Gabapentin: Dizziness as a Side Effect

Pregabalin does not cause less dizziness than gabapentin; both medications have similar rates of dizziness as a side effect. 1, 2

Side Effect Profiles

  • Both pregabalin and gabapentin commonly cause dizziness, with pregabalin causing dizziness in 23-46% of patients 2
  • The most common side effects for both medications include dizziness, somnolence, dry mouth, and constipation 1
  • Dizziness is dose-dependent for both medications and can be managed by dose reduction or slower titration 3
  • Both medications can also cause peripheral edema and weight gain, particularly in elderly patients 1, 4

Pharmacokinetic Differences

  • While the side effect profiles are similar, pregabalin has more predictable absorption and linear pharmacokinetics compared to gabapentin 2, 5
  • Pregabalin is absorbed more rapidly (peak plasma concentration within 1 hour) compared to gabapentin (3-4 hours) 5
  • Gabapentin exhibits saturable absorption (nonlinear), making its pharmacokinetics less predictable, while pregabalin has linear absorption with plasma concentrations increasing proportionately with dose 5
  • The absolute bioavailability of gabapentin drops from 60% to 33% as dosage increases from 900 to 3600 mg/day, while pregabalin maintains ≥90% bioavailability regardless of dose 5

Dosing Considerations

  • Pregabalin's starting dose is typically 50 mg three times daily or 75 mg twice daily, with maximum dose of 600 mg/day 1, 2
  • Gabapentin is usually started at 100-300 mg at bedtime or 100-300 mg three times daily, with maximum dose of 3600 mg/day 1
  • Both medications require dosage reduction in patients with renal impairment 1, 2
  • For elderly patients, lower starting doses and slower titration are recommended for both medications to minimize side effects, particularly dizziness 1, 2

Clinical Implications

  • When switching between these medications, consider that the side effect profiles are similar, particularly regarding dizziness 2, 5
  • To minimize dizziness with either medication:
    • Start with lower doses (pregabalin: 25-50 mg/day; gabapentin: 100-200 mg/day) 1
    • Implement slow dose escalation with adequate intervals to monitor effects 1
    • Consider divided dosing to minimize peak-related side effects 1
  • For patients experiencing intolerable dizziness with one medication, switching to the other may not necessarily reduce this side effect 1, 2, 3

Monitoring Recommendations

  • Monitor all patients for dizziness, somnolence, and other neurological side effects, especially during dose titration 1
  • Be particularly cautious in elderly patients who may be more susceptible to falls due to dizziness 1, 2
  • Consider dose reduction rather than discontinuation if dizziness occurs, as these side effects are typically dose-dependent 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pregabalin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Pregabalin--profile of efficacy and tolerability in neuropathic pain].

Drugs of today (Barcelona, Spain : 1998), 2009

Research

Possible heart failure associated with pregabalin use: case report.

Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.